Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
March 31, 2023 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
March 31, 2023 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered...
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
March 29, 2023 08:55 ET
|
Bioventus, Inc.
DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now...
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
March 16, 2023 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition
February 28, 2023 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered...
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present...
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
November 21, 2022 17:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today amended its previously announced...
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
November 16, 2022 17:15 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company has filed...
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
November 08, 2022 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
October 31, 2022 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...